Axovant and Yposkesi Sign Strategic Gene Therapy Development and Manufacturing Partnership
BASEL, Switzerland and CORBEIL-ESSONNES, France, June 20, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announces it has signed a strategic partnership with …